Mersana Therapeutics, Inc.
MRSNDelisted Jan 6, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001442836
Mersana Therapeutics, Inc. was delisted on Jan 6, 2026; its insiders filed their last Form 4 on Jan 6, 2026; 51 institutions reported holding it in 13F filings for Q4 2025, worth $64.8M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Mersana Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 125 | 122 | −3 |
| Shares | 117.5M | 114.2M | −3.29M (−2.8%) |
| Value | $526.3M | $229.6M | −$296.8M (−56.4%) |
New holders (19)
Institutions that held Mersana Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 259,689 | $521.0K | 0.00% |
| Squarepoint Ops LLC | 252,804 | $508.1K | 0.00% |
| Superstring Capital Management LP | 110,073 | $221.2K | 0.28% |
| ExodusPoint Capital Management, LP | 107,174 | $215.0K | 0.00% |
| Corebridge Financial, Inc. | 61,030 | $122.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 56,945 | $114.5K | 0.00% |
| Graham Capital Management, L.P. | 50,970 | $102.5K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 46,779 | $94.0K | 0.01% |
| Algert Global LLC | 44,655 | $89.8K | 0.00% |
| Group One Trading, L.P. | 23,470 | $47.2K | 0.00% |
| Public Employees Retirement System of Ohio | 20,587 | $41.4K | 0.00% |
| AJOVista, LLC | 20,463 | $41.1K | 0.12% |
| Caption Management, LLC | 10,200 | $20.5K | 0.00% |
| State of Wyoming | 9,158 | $18.4K | 0.00% |
| Smartleaf Asset Management LLC | 1,911 | $3.81K | 0.00% |
| Catalyst Funds Management Pty Ltd | 1,700 | $3.42K | 0.00% |
| Optiver Holding B.V. | 1,586 | $3.19K | 0.00% |
| Nordwand Advisors, LLC | 1,500 | $3.02K | 0.00% |
| Picton Mahoney Asset Management | 670 | $1.00K | 0.00% |
Sold out (22)
Institutions that held Mersana Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.